Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-12 Purchase |
2023-12-14 6:21 pm |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
67,881 | $1.0199 | $69,233 | 6,686,387 (Indirect Direct) |
View |
| 2023-12-05 Purchase |
2023-12-07 6:30 pm |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
57,369 | $1.0133 | $58,134 | 4,316,215 (Indirect Direct) |
View |
| 2023-11-29 Purchase |
2023-12-01 1:38 pm |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
43,134 | $0.94 | $40,546 | 4,258,846 (Indirect Direct) |
View |
| 2023-08-30 Purchase |
2023-08-31 6:42 pm |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
82,052 | $1.315 | $107,898 | 4,215,712 (Indirect Direct) |
View |
| 2023-08-15 Purchase |
2023-08-17 6:08 pm |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
250,000 | $1.3029 | $325,737 | 4,133,660 (Indirect Direct) |
View |
| 2022-05-20 Purchase |
2022-05-23 6:18 pm |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
66,500 | $3.1707 | $210,850 | 1,077,519 (Indirect) |
View |
| 2021-04-06 Purchase |
2021-04-07 6:47 pm |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
25,000 | $42 | $1,050,000 | 1,011,019 (Indirect) |
View |
| 2021-03-24 Purchase |
2021-03-24 9:06 pm |
Cortexyme Inc. | CRTX | Lamond David Director |
50,000 | $33.77 | $1,688,500 | 3,683,658 (Indirect Direct) |
View |
| 2021-03-04 Purchase |
2021-03-05 5:54 pm |
Cortexyme Inc. | CRTX | Lamond David Director |
50,000 | $35.34 | $1,767,057 | 2,098,938 (Indirect Direct) |
View |
| 2020-06-04 Purchase |
2020-06-08 6:47 pm |
Cortexyme Inc. | CRTX | Lamond David Director |
49,125 | $43.27 | $2,125,795 | 2,048,938 (Indirect Direct) |
View |
| 2020-05-15 Purchase |
2020-05-19 6:41 pm |
Cortexyme Inc. | CRTX | Lamond David Director |
44,648 | $55.35 | $2,471,251 | 1,999,813 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-08 7:30 pm |
N/A 2035-01-02 |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
47,587 | $0 | 47,587 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 9:08 pm |
2025-06-05 2034-06-05 |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-26 5:47 pm |
N/A 2033-05-23 |
Quince Therapeutics Inc. | QNCX | Lamond David Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 8:43 pm |
N/A 2032-06-07 |
Cortexyme Inc. | CRTX | Lamond David Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:38 pm |
N/A 2032-05-31 |
Lucira Health Inc. | LHDX | Lamond David Director |
59,459 | $0 | 59,459 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 5:17 pm |
N/A 2032-05-24 |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-23 8:09 pm |
N/A N/A |
Cortexyme Inc. | CRTX | Lamond David Director |
200,002 | $0 | 3,883,660 (Indirect) |
View |
| 2021-06-16 Option Award |
2021-06-17 7:25 pm |
N/A 2031-06-15 |
Cortexyme Inc. | CRTX | Lamond David Director |
11,029 | $0 | 11,029 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-20 7:05 pm |
N/A 2031-05-18 |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
15,175 | $0 | 15,175 (Direct) |
View |
| 2021-03-04 Gift |
2021-03-23 7:13 pm |
N/A N/A |
Cortexyme Inc. | CRTX | Lamond David Director |
1,534,720 | $0 | 3,633,658 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 7:50 pm |
N/A N/A |
Lucira Health Inc. | LHDX | Lamond David Director |
146,385 | $0 | 271,666 (Indirect) |
View |
Ownership |
2021-02-04 6:28 pm |
N/A N/A |
Lucira Health Inc. | LHDX | Lamond David Director |
0 | $0 | 271,666 (Direct) |
View |
| 2020-06-09 Conversion |
2020-06-11 6:38 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
914,592 | $0 | 986,019 (Indirect) |
View |
| 2020-06-09 Option Award |
2020-06-11 6:38 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
71,430 | $14 | 986,019 (Indirect) |
View |
| 2020-06-08 Option Award |
2020-06-09 8:12 pm |
N/A 2030-06-07 |
Cortexyme Inc. | CRTX | Lamond David Director |
11,029 | $0 | 11,029 (Direct) |
View |
Ownership |
2020-06-04 7:30 pm |
N/A N/A |
Applied Molecular Transport Inc. | AMTI | Lamond David Director |
0 | $0 | 914,589 (Indirect) |
View |